Cholecalciferol Supplementation Attenuates Bone Loss in Incident Kidney Transplant Recipients: A Prespecified Secondary Endpoint Analysis of a Randomized Controlled Trial

Vitamin D deficiency, persistent hyperparathyroidism, and bone loss are common after kidney transplantation (KTx). However, limited evidence exists regarding the effects of cholecalciferol supplementation on parathyroid hormone (PTH) and bone loss after KTx. In this prespecified secondary endpoint a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsujita, Makoto, Doi, Yohei, Obi, Yoshitsugu, Hamano, Takayuki, Tomosugi, Toshihide, Futamura, Kenta, Okada, Manabu, Hiramitsu, Takahisa, Goto, Norihiko, Isaka, Yoshitaka, Takeda, Asami, Narumi, Shunji, Watarai, Yoshihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298992/
https://www.ncbi.nlm.nih.gov/pubmed/34747516
http://dx.doi.org/10.1002/jbmr.4469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298992/
https://www.ncbi.nlm.nih.gov/pubmed/34747516
http://dx.doi.org/10.1002/jbmr.4469

Ejemplares similares